RSS feed

Publications by Jonas Hallén

17 publications found

Original articles

Hallén J, Atar D, Serebruany V (2014)
Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease
Am J Ther, 21 (2), 91-8
DOI 10.1097/MJT.0b013e3181b0a6ff, PubMed 19770797

Hallén J, Jensen JK, Buser P, Jaffe AS, Atar D (2011)
Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction
Acute Card Care, 13 (1), 48-51
DOI 10.3109/17482941.2010.538698, PubMed 21244230

Hallén J, Jensen JK, Fagerland MW, Jaffe AS, Atar D (2010)
Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction
Heart, 96 (23), 1892-7
DOI 10.1136/hrt.2009.190819, PubMed 21062778

Hallén J, Atar D (2010)
A window into your heart: taking cardiac troponin to the next level
Biomark Med, 4 (6), 889-94
DOI 10.2217/bmm.10.103, PubMed 21133709

Hallén J, Madsen L, Ladefoged S, Fagerland MW, Serebruany VL, Agewall S, Atar D (2010)
Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease
Scand J Urol Nephrol, 45 (2), 151-8
DOI 10.3109/00365599.2010.529819, PubMed 21091090

Slettaløkken G, Rehn TA, Munkvik M, Rud B, Sökjer-Petersen M, Lunde PK, Sjaastad I, Sejersted OM, Hallén J (2010)
Preserved metabolic reserve capacity in skeletal muscle of post-infarction heart failure patients
Scand J Med Sci Sports, 22 (2), 199-206
DOI 10.1111/j.1600-0838.2010.01226.x, PubMed 20874858

Hallén J, Johansen OE, Birkeland KI, Gullestad L, Aakhus S, Endresen K, Tjora S, Jaffe AS, Atar D (2010)
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus
Cardiovasc Diabetol, 9, 52
DOI 10.1186/1475-2840-9-52, PubMed 20843304

Hallén J, Petzelbauer P, Schwitter J, Geudelin B, Buser P, Atar D (2010)
Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial
EuroIntervention, 5 (8), 946-52
DOI 10.4244/EIJV5I8A159, PubMed 20542780

Hallén J, Sejersten M, Johanson P, Atar D, Clemmensen PM (2010)
Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention
Am J Cardiol, 105 (9), 1223-8
DOI 10.1016/j.amjcard.2009.12.034, PubMed 20403470

Losnegard T, Mikkelsen K, Rønnestad BR, Hallén J, Rud B, Raastad T (2010)
The effect of heavy strength training on muscle mass and physical performance in elite cross country skiers
Scand J Med Sci Sports, 21 (3), 389-401
DOI 10.1111/j.1600-0838.2009.01074.x, PubMed 20136751

Hallén J, Buser P, Schwitter J, Petzelbauer P, Geudelin B, Fagerland MW, Jaffe AS, Atar D (2009)
Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction
Am J Cardiol, 104 (11), 1472-7
DOI 10.1016/j.amjcard.2009.07.019, PubMed 19932777

Rud B, Christensen CC, Ryg M, Edvardsen A, Skumlien S, Hallén J (2009)
Higher skeletal muscular metabolic reserve capacity in COPD patients than healthy subjects
Scand J Med Sci Sports, 19 (6), 857-64
DOI 10.1111/j.1600-0838.2008.00846.x, PubMed 19508654

Paulsen G, Lauritzen F, Bayer ML, Kalhovde JM, Ugelstad I, Owe SG, Hallén J, Bergersen LH, Raastad T (2009)
Subcellular movement and expression of HSP27, alphaB-crystallin, and HSP70 after two bouts of eccentric exercise in humans
J Appl Physiol (1985), 107 (2), 570-82
DOI 10.1152/japplphysiol.00209.2009, PubMed 19498098

Paulsen G, Egner IM, Drange M, Langberg H, Benestad HB, Fjeld JG, Hallén J, Raastad T (2009)
A COX-2 inhibitor reduces muscle soreness, but does not influence recovery and adaptation after eccentric exercise
Scand J Med Sci Sports, 20 (1), e195-207
DOI 10.1111/j.1600-0838.2009.00947.x, PubMed 19522751

Other articles

Kjeldsen K, Atar D, Hallén J, Vardas P, Zannad F, Haunsø S (2010)
Sudden cardiac death--the challenge to cardiology
Fundam Clin Pharmacol, 24 (5), 535-7
DOI 10.1111/j.1472-8206.2010.00875_3.x, PubMed 20854303

Hallén J, Atar D, Sejersten M, Clemmensen P, Johanson P (2010)
Optimal time-point of ST-segment assessment for risk-stratification following primary percutaneous coronary intervention
Am J Cardiol, 105 (11), 1648-9; author reply 1649-50
DOI 10.1016/j.amjcard.2010.03.006, PubMed 20494681

Hallén J, Atar D (2009)
In ST-Elevation myocardial infarction patients receiving primary percutaneous coronary intervention, admission cardiac troponin T and peak cardiac troponin T values differ in their prognostic properties
Am J Cardiol, 103 (9), 1331
DOI 10.1016/j.amjcard.2009.02.032, PubMed 19406285